Your browser doesn't support javascript.
loading
The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages.
Martin, Darren P; Weaver, Steven; Tegally, Houriiyah; San, James Emmanuel; Shank, Stephen D; Wilkinson, Eduan; Lucaci, Alexander G; Giandhari, Jennifer; Naidoo, Sureshnee; Pillay, Yeshnee; Singh, Lavanya; Lessells, Richard J; Gupta, Ravindra K; Wertheim, Joel O; Nekturenko, Anton; Murrell, Ben; Harkins, Gordon W; Lemey, Philippe; MacLean, Oscar A; Robertson, David L; de Oliveira, Tulio; Kosakovsky Pond, Sergei L.
Afiliação
  • Martin DP; Institute of Infectious Diseases and Molecular Medicine, Division Of Computational Biology, Department of Integrative Biomedical Sciences, University of Cape Town, Cape Town 7701, South Africa. Electronic address: darrenpatrickmartin@gmail.com.
  • Weaver S; Institute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Philadelphia, PA 19122, USA.
  • Tegally H; KwaZulu-Natal Research Innovation and Sequencing Platform, School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban 4001, South Africa.
  • San JE; KwaZulu-Natal Research Innovation and Sequencing Platform, School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban 4001, South Africa.
  • Shank SD; Institute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Philadelphia, PA 19122, USA.
  • Wilkinson E; KwaZulu-Natal Research Innovation and Sequencing Platform, School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban 4001, South Africa.
  • Lucaci AG; Institute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Philadelphia, PA 19122, USA.
  • Giandhari J; KwaZulu-Natal Research Innovation and Sequencing Platform, School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban 4001, South Africa.
  • Naidoo S; KwaZulu-Natal Research Innovation and Sequencing Platform, School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban 4001, South Africa.
  • Pillay Y; KwaZulu-Natal Research Innovation and Sequencing Platform, School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban 4001, South Africa.
  • Singh L; KwaZulu-Natal Research Innovation and Sequencing Platform, School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban 4001, South Africa.
  • Lessells RJ; KwaZulu-Natal Research Innovation and Sequencing Platform, School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban 4001, South Africa.
  • Gupta RK; Clinical Microbiology, University of Cambridge, Cambridge CB2 1TN, UK; Africa Health Research Institute, KwaZulu-Natal 4013, South Africa.
  • Wertheim JO; Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
  • Nekturenko A; Department of Biochemistry and Molecular Biology, The Pennsylvania State University, State College, PA 16802, USA.
  • Murrell B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 141 83, Sweden.
  • Harkins GW; South African Medical Research Council Capacity Development Unit, South African National Bioinformatics Institute, University of the Western Cape, Bellville 7635, South Africa.
  • Lemey P; Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven 3000, Belgium.
  • MacLean OA; MRC-University of Glasgow Centre for Virus Research, Glasgow 12 8QQ, Scotland, UK.
  • Robertson DL; MRC-University of Glasgow Centre for Virus Research, Glasgow 12 8QQ, Scotland, UK.
  • de Oliveira T; KwaZulu-Natal Research Innovation and Sequencing Platform, School of Laboratory Medicine & Medical Sciences, University of KwaZulu- Natal, Durban 4001, South Africa; Department of Global Health, University of Washington, Seattle, WA 98195-4550, USA. Electronic address: tuliodna@gmail.com.
  • Kosakovsky Pond SL; Institute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Philadelphia, PA 19122, USA. Electronic address: spond@temple.edu.
Cell ; 184(20): 5189-5200.e7, 2021 09 30.
Article em En | MEDLINE | ID: mdl-34537136
The independent emergence late in 2020 of the B.1.1.7, B.1.351, and P.1 lineages of SARS-CoV-2 prompted renewed concerns about the evolutionary capacity of this virus to overcome public health interventions and rising population immunity. Here, by examining patterns of synonymous and non-synonymous mutations that have accumulated in SARS-CoV-2 genomes since the pandemic began, we find that the emergence of these three "501Y lineages" coincided with a major global shift in the selective forces acting on various SARS-CoV-2 genes. Following their emergence, the adaptive evolution of 501Y lineage viruses has involved repeated selectively favored convergent mutations at 35 genome sites, mutations we refer to as the 501Y meta-signature. The ongoing convergence of viruses in many other lineages on this meta-signature suggests that it includes multiple mutation combinations capable of promoting the persistence of diverse SARS-CoV-2 lineages in the face of mounting host immune recognition.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Evolução Molecular / Pandemias / SARS-CoV-2 / COVID-19 / Mutação Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Evolução Molecular / Pandemias / SARS-CoV-2 / COVID-19 / Mutação Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article